Professor Richard Sullivan is Professor, Cancer Policy & Global Health at Kings College London and founding director of the new Kings Institute of Cancer Policy. Professor Sullivan is an executive member of the Kings Health Partners Cancer Centre where he leads the international strategy and is also Visiting Professor at the Faculty of Medicine, Universidad Catolica, Chile. Professor Sullivan also serves on Centre for Global Health at Kings and the Marjan Centre for Conflict & Conservation.
Professor Sullivan qualified in medicine at St. Marys Hospital, London. Following training in surgery (onco-urology) he undertook a PhD and post-doctoral research in cell signalling at University College London. He then worked in a senior role in the pharmaceutical industry before spending nearly a decade with one of the worlds biggest NGO funders of cancer research Cancer Research UK as their clinical director. There he led on a number of major strategies including developing and launching the UK’s Experimental Cancer Medicine Centres and the development of the European Comprehensive Cancer Centres program. In 2008 Professor Sullivan moved back into research at the London School of Economics were he studied complex healthcare systems within the health, society and population programme having previously worked in conflict and post conflict public health settings in the Balkans, Africa and most recently Middle East. He serves on a wide variety of advisory boards, including Charite Comprehensive Cancer Centre Berlin, Irish Clinical Oncology Group, et al. He is past UK Director of the Council for Emerging National Security Affairs (CENSA) a Washington-based national security thinktank where he specialised in counter-proliferation and the security implications of global health, and has been a special advisor to many international organisations.
Professor Sullivan’s research programmes focus on two areas: global cancer policy and conflict & health focusing on public health systems in high-risk, conflict areas focusing on DR Congo, Afghanistan & Libya. He leads a number of programs including studies of the basic package of health services in Afghanistan, armed violence reduction and public health and the relationship between security and global health.
In global cancer public policy Professor Sullivan has led on a number of major Lancet Oncology Commissions examining the affordability of cancer in high-income countries, global childhood cancer care and most recently cancer care in Latin America. His research interests span from the study of national cancer research systems to the relationship between research and cancer outcomes. The ICP’s current portfolio of global cancer policy includes studies of the economic impact of cancer across Europe, global surgery, designing affordable cancer care systems for high income and emerging countries, cancer and ageing, affordable care in India in the context of Universal Health Coverage and new models of global and European childhood cancer research.